Hsv-2 Infection
Hsv-2 Infection - Related Videos
02:48
Labeling of Replicating HSV-1 Genomes with a Nucleoside Analog
0 Views •
2026
Source: Dembowski, J. A., Deluca, N. A. Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins. J. Vis. Exp. (2017)This video demonstrates the infection of stationary-phase mammalian cells with HSV-1 (Herpes Simplex Virus-1), followed by replication of the viral genome using host and viral replication machinery. A synthetic nucleoside analog is incorporated into newly synthesized viral DNA to label replicating genomes, which are subsequently isolated for...
07:30
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
0 Views •
Cited by 8 •
2016
This article describes how to inject viral vectors into the mouse frontal cortex to test behavioral assays that require GPCR heteromeric formation.
08:50
Direct Observation of Phagocytosis and NET-formation by Neutrophils in Infected Lungs using 2-photon Microscopy
0 Views •
Cited by 21 •
2011
We show, how to use 2-photon microscopy for the observation of the dynamics of neutrophil granulocytes in infected lungs while they phagocytose pathogens or produce neutrophil extracellular traps (NETs).
08:56
Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells
0 Views •
Cited by 4 •
2018
Here, we present protocols to visualize calcium (Ca2+) responses elicited by HeLa cells infected by Shigella. By optimizing the parameters of bacterial infection and imaging with Ca2+ fluorescent probes, atypical global and local Ca2+ signals induced by bacteria over a large range of infection kinetics are characterized.
12:33
Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi
0 Views •
Cited by 3 •
2016
A method is described herein for the determination of inter-Kingdom association and competition (bacterial and fungal) for adherence to virus-infected HeLa cell monolayers. This protocol can be extended to multiple combinations of prokaryotes, eukaryotes, and viruses.
FAQs
After entering epithelial cells, HSV-2 replicates locally before moving along sensory neurons. This sequence connects the initial activity at skin or mucous membranes with the virus’s longer-term presence in nerve ganglia. Understanding both locations helps explain why infection can involve an early local phase and later episodes associated with viral reactivation.
Sensory neurons provide a route for HSV-2 to establish lifelong latency in nerve ganglia. During latency, the virus is not described as continuously producing visible lesions, but it can later reactivate and return to the skin. This biological cycle is central to research on recurrence, persistence, and methods for controlling infection.
Transmission can occur through asymptomatic shedding, meaning virus may be present and released even when visible lesions are absent. This explains why relying only on noticeable outbreaks does not fully identify periods of transmission risk. The mechanism is important for counseling and for developing prevention strategies that address both symptomatic and symptom-free intervals.
Immune responses are a major research focus because HSV-2 persists in the body and can reactivate after latency. Studying how the host responds to viral activity may clarify why infection remains lifelong and how reactivation is controlled. These questions also contribute to broader efforts to improve prevention approaches, including vaccine development.
Accurate diagnostic testing helps distinguish infection in a condition that may occur without noticeable symptoms. Within clinical and biological research, testing supports more informed evaluation alongside antiviral treatment and counseling. Its importance extends beyond identifying visible disease because asymptomatic infection and shedding can influence transmission and prevention decisions.
Antiviral treatment and counseling contribute in different but complementary ways. Treatment is part of the clinical response to infection, whereas counseling helps address transmission, symptom awareness, and prevention. Considering both reflects the biology of HSV-2, in which local lesions, lifelong latency, and asymptomatic shedding can all affect patient care and communication.
Research examines how HSV-2 establishes and maintains latency, what influences reactivation, how transmission occurs during asymptomatic shedding, and how immune responses shape infection. Vaccine development is another important goal. Together, these areas connect molecular and cellular biology with practical needs in diagnosis, treatment, counseling, and prevention.